Lulu Jiang, MD, PhD, an assistant professor in the Department of Neuroscience at UVA School of Medicine, was awarded a $3.6 million R01 grant from the National Institute on Aging for her project ti
Head of Harrison Family Translational Research Center discusses advances in treatment.
The family of the late David and Mary Harrison, two of the University of Virginia’s most generous benefactors, has made a pair of commitments totaling $55 million to the Olympic Sports Center in th
Alzheimer’s researchers at the University of Virginia have discovered how harmful tau proteins damage the essential operating instructions for our brain cells, a finding which could lead to new tre
A University of Virginia professor is collaborating on a deep brain implant that may one day be the path by which doctors treat and perhaps reverse the degenerative effects of Alzheimer’s disease.
Professor Chia-Yi “Alex” Kuan, MD, PhD, in the Department of Neuroscience, was awarded a new NIH R01 grant for $3 million to study the mechanisms of a pathological hallmark of Alzheimer’s disease,
The discovery suggests enhanced light sensitivity may contribute to “sundowning” — the worsening of symptoms late in the day — and spur sleep disruptions thought to contribute to the disease’s prog
University of Virginia biology professor George Bloom is receiving revived interest lately in an old paper.
The new discovery advances the battle against the disease, which strikes 1 in 9 people over age 65.
A UVA discovery could eventually protect patients from brain diseases that rob them of memory and motion.
A nursing professor is testing a novel, UVA-developed digital health intervention that might help older adults with both conditions.
University of Virginia neuroscientist George Bloom, PhD, studies how Alzheimer's disease develops biochemically in order to imp